Purchase Order – 心脏生物科技 (CBSC)

CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

CBSC宣布37.5万美元采购订单及循环收入项目

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.

News

0 Comments

How can we help you?

Tell us what you are interested in.

Contact Us